The FDA Backdoor to MDMA Rescheduling
FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.
mdma
-
Read more: The FDA Backdoor to MDMA Rescheduling -
Read more: Sorry, You Probably Cannot Get MDMA Through Telehealth Sorry, You Probably Cannot Get MDMA Through Telehealth
Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.
-
Read more: Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control
Historic and contemporary discussions on psychedelic and MDMA research largely ignore theories on power, control, and abusive interpersonal relationships.
-
Read more: Psychedelics Are Cheap. Psychedelic Treatment Is Not. Psychedelics Are Cheap. Psychedelic Treatment Is Not.
Psychedelics hold promise to address an array of conditions, but potential benefits may be stratified along the lines of socioeconomic status.
-
Read more: What Macrodosing Can Learn from Microdosing What Macrodosing Can Learn from Microdosing
While standard doses of psychedelics will ostensibly be higher than a microdose, the question of just how much higher should be the topic of debate.
-
Read more: A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.
-
Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative
“The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries,” Marks explains.
